As 2023 draws to a close, we look back on some of the major clinical highlights from the year gone by.
As the COVID-19 pandemic continues to evolve with fluctuating restrictions worldwide, mass vaccine rollouts and the emergence of new variants, it's...
Extremely precise biosensors embedded into clothing could inform doctors or scientists that they've been exposed to a dangerous germ. The sensors can...
We have added three clinical trials to our comprehensive database of the current CRISPR-based trials for gene-editing therapies and diagnostics. This...
When CRISPR-Cas9 was first adapted to eukaryotic genome editing in 2012, scientists worldwide immediately saw its huge potential in basic science,...
As the coronavirus pandemic continues, scientists worldwide redeploy their resources to join the battle against the SARS-CoV-2 virus. One diverse team...
New research opens the door to RNA editing therapies that can influence gene expression without making permanent genetic changes. Neville Sanjana’s...
For the first time, the FDA has authorized a CRISPR gene-editing tool - the COVID 19 diagnostic kit developed by Sherlock Biosciences, here CEO Rahul...
